Basking in praise and a $4.2B GSK pact, Merck KGaA blueprints expansion plans for Boston-area R&D campus
Fresh on the heels of announcing a multibillion-dollar development pact with GlaxoSmithKline, Merck KGaA is showing off its blueprint for a big expansion of its R&D operations in Billerica, outside of Boston.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.